Martinez Diaz, Susana
Bhojani, Naeem
Elterman, Dean
Zorn, Kevin
Kaplan, Steven A.
Kohler, Tobias S.
Lerner, Lori B.
McVary, Kevin T.
Rutman, Matthew P.
Welliver, Charles
Te, Alexis E.
Sedrakyan, Art
Chughtai, Bilal http://orcid.org/0000-0002-0515-2578
Article History
Received: 18 April 2022
Accepted: 12 September 2022
First Online: 11 October 2022
Declarations
:
: Naeem Bhojani is a consultant for Olympus, Boston Scientific, and Procept BioRobotics. Dean Elterman is a consultant for Olympus, Boston Scientific, and Procept BioRobotics. Matthew Rutman is a consultant for Boston Scientific. Charles Welliver is compensated for Continuing Medical Education (CME) content from Oakstone publishing and Medscape. Alexis Te is a consultant for PROCEPT BioRobotics, Urotronic, and Zenflow. Bilal Chughtai is a consultant for Olympus, Boston Scientific, Medeon Bio, and Allergan. The other authors declare that they have no known competing interests.
: Study was approved by the WCM Institutional Review Board (IRB #1601016896) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.